EMAIL THIS PAGE TO A FRIEND

Drug delivery

Polymeric nanospheres modified with YIGSR peptide for tumor targeting.


PMID 20560774

Abstract

YIGSR peptide anchored pegylated nanospheres (YIGSR-SN) loaded with 5-fluorouracil (5-FU) were investigated for selective and preferential presentation of carrier contents at angiogenic endothelial cells over-expressing laminin receptors on and around tumor tissue and thus for assessing their targetability. Pegylated nanosphere (SN) without peptide conjugate were used for comparison. The average size of all nanosphere preparations prepared was approximately 108 nm and maximum drug entrapment was 68.5 +/- 5.2%. In vitro endothelial cell binding of nanospheres exhibited 8-fold higher binding of YIGSR-SN to HUVEC in comparison to the SN. Spontaneous lung metastasis and angiogenesis assays show that YIGSR peptide anchored nanospheres are significantly (p

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T7154
Tyr-Ile-Gly-Ser-Arg, ≥97% (HPLC)
C26H42N8O8